Equitable Allocation of COVID-19 Vaccines: An Analysis of the Initial Allocation Plans of CDC’s Jurisdictions with Implications for Disparate Impact Monitoring

December 3, 2020

SSRN

Read the full article

Authors

Harald Schmidt, Rebecca Weintraub, Michelle A. Williams, Alison Buttenheim, Emily Sadecki, Helen Wu, Aditi Doiphode, Lawrence O. Gostin, Angela A. Shen

CHIBE Experts

Research Areas

Measuring Quality-Weighted Hospital-Free-Days in Acute Respiratory Failure: A Modified Delphi Study

Annals of the American Thoracic Society

March 20, 2024
Trust in Federal COVID-19 Vaccine Oversight and Parents’ Willingness To Vaccinate Their Children Against COVID-19: A Cross-Sectional Study

BMC Public Health

March 16, 2024
Field Testing the Transferability of Behavioural Science Knowledge on Promoting Vaccinations

Nature Human Behaviour

March 14, 2024
Health Care Use Among Patients Retroactively Insured via a Hospital-Based Insurance Linkage Program

Journal of General Internal Medicine

March 14, 2024
Mobile Delivery of COVID-19 Vaccines Improved Uptake in Rural Sierra Leone

Nature

March 13, 2024
The Impact of Health Care Algorithms on Racial and Ethnic Disparities : A Systematic Review

Annals of Internal Medicine

March 12, 2024
Perspectives of Black Patients on Racism Within Emergency Care

JAMA Health Forum

March 8, 2024
The Next Decade of Healthcare

Healthcare

February 29, 2024
Changes in Health Care Workers' Economic Outcomes Following Medicaid Expansion

JAMA

February 27, 2024
Health Care Resource Utilization and Costs Associated With Diagnosed Medication Overuse Headache and Potential Acute Medication Overuse in Individuals With Migraine

Cephalalgia

February 27, 2024
Evaluating the Implementation of a Community Health Worker-Delivered Intervention Integrating Asthma Care in West Philadelphia Public Schools

Journal of Asthma

February 9, 2024
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting

Clinical Lymphoma Myeloma Leukemia

February 8, 2024